Canopy Growth Corp T.WEED

Alternate Symbol(s): T.WEED.DB | CGC

Healthcare Cannabis

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

TSX:WEED - Post by User

Canopy Growth Corp > Does Canopy deserve double the market cap of US rivals

<< Previous

Bullboard Posts

Next >>

Comment by Homestretch4meon Sep 17, 2021 2:26pm

135 Views

Post# 33878539

RE:RE:RE:RE:RE:Does Canopy deserve double the market cap of US rivals

Hey asshat? Answer one question for me. Is constellation Brands a Canadian or American company? Thank you. That's all.

YodaLayhehoo wrote:
WeedTheNorth wrote: I'll add they are trapped in the US while Canadian LPs can be invested in any other countries, in Germany, in the UK etc.
YodaLayhehoo wrote:
WeedTheNorth wrote: No US cannabis company can write off spending. That means they spend on anything and there are no deductions. Legal Canadian companies can write most everything off. It counts for a lot the markets are telling you.
YodaLayhehoo wrote:
We know the US companies make more than Canopy and are more profitable than Canopy yet Canopy trades at a huge premium. Canopy trades at double TRUL. Either TRUL needs to double in price or Canopy needs to be more than cut in half making it $9-10 per share. CURA trades in line with Canopy probably due to their charismatic chairman. Companies like TER and Gage merger have sales higher than canopy in a rapidly growing market and have market caps 25% of Canopy. Either they move up or canopy moves down to meet them eventually.

So we have one answer "write offs" are worth 4 billion in the market. Anything else?

You're either a kid or have no idea what is going on. The US companies are already invested in Europe and will go anywhere Canopy can go. The past couple days should have shown you exactly what's going to happen. The US companies took off 6-7% in one day and Canopy went down. This is exactly how it's going to play out over the next few years. Canopy is a small company now and getting smaller everyday and they are valued as the largest company. I don't see anything good about Canopy at the moment. They can't compete in the US there's no catalyst anywhere in sight for them.

As for the US companies they have:

Safe banking

Uplisting

They're profitable companies

Their market is at least 10x Canopy's

They're trading at lower valuations

They have little to no funds or banks in the game.

Use the force little one pull the blinders off your eyes. The money will flow to the US you don't have to be a genius to see it